We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals

51 hedge funds and large institutions have $361M invested in Mirum Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

0.29% less ownership

Funds ownership: 74.08% → 73.79% (-0.29%)

9% less capital inflows, than outflows

Capital inflows: $10.7M | Capital outflows: $11.8M

12% less funds holding

Funds holding: 58 → 51 (-7)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

88% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 8

Holders
51
Holders Change
-7
Holders Change %
-12.07%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
1
Increased
21
Reduced
19
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MIRM Hedge Fund Activity: Q3 2020 in Review

51 of the 4,972 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q3 2020, worth a combined $361M — down 1.3% from $366M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of MIRM and 1 opened new positions — a net loss of 7 holders — while 19 trimmed existing stakes and 21 added.

The largest buyer was Millennium Management, adding an estimated $4.3M. The largest seller was Sofinnova Investments, cutting an estimated $4.73M.

  • 51 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q3 2020, down from 58 in Q2 2020.
  • Funds reported $361M of Mirum Pharmaceuticals stock for Q3 2020, down 1.3% quarter-over-quarter.
  • 1 fund opened new Mirum Pharmaceuticals positions in Q3 2020 and 8 closed out, a net change of -7 holders.
  • The largest Mirum Pharmaceuticals buyer in Q3 2020 was Millennium Management, an estimated $4.3M added.
  • The largest Mirum Pharmaceuticals seller in Q3 2020 was Sofinnova Investments, an estimated $4.73M sold.

Based on aggregated 13F filings for Q3 2020.